HDAC11 and ovarian carcinoma: In addition, the Cancer Genome Atlas shows that HDAC11 promoter methylation is associated with a poor prognosis of ovarian cancer patients (Dai et al., 2013), suggesting the need for in-depth studies of the specific mechanisms of HDAC11 in specific tumors.